Test targeted radiation to control many metastases safely
Part of Cancer clinical trials.
This study tests whether a focused, high-precision type of radiation can control many cancer spread-out spots (“metastases”) at the same time, while keeping side effects acceptable. It may help people with many metastases live longer or have better disease control by aiming treatment at every treatable spot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older, and you can understand and sign consent forms
- Your overall health is good enough for treatment (ECOG 0 to 2) and you have at least 6 months to live
- Your cancer has spread to multiple places on scans, and all known spots can be planned safely for radiation
- You have at least 11 metastases you can treat (and if the main tumor is treated, you may need at least 12 targets total)
- You can get a detailed scan work-up within 12 weeks (often brain MRI, plus whole-body imaging such as PET/CT)
- You’ll be off most cancer medicines (chemotherapy/targeted therapy/immunotherapy) for 3 months, unless it’s hormone treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise, high-dose radiation technique (SABR) for people whose cancer has started to grow again in only a few spots despite ongoing medication. The goal is to control those new growths while continuing your current treatment.
This study tests a precise radiation technique called SABR to treat cancer that has spread to a few spots. It aims to see if this approach can help control the cancer better than usual treatment, especially for lung, prostate, colorectal, or other solid tumors with limited spread.
This trial tests whether adding focused, high-dose radiation (SABR) to standard drug therapy can better control cancer that has spread to a few spots in the body. It is for people starting or resuming cancer medicines for newly found or growing metastases.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This study tests whether giving focused radiation (SABR) to a few growing spots of breast cancer, while continuing your current hormone therapy and CDK 4/6 inhibitor, can help control the cancer longer than switching to a different treatment. It is for people whose cancer is mostly stable but has a small number of spots that have started to grow.
This trial tests whether giving one strong dose of radiation is as good as several smaller doses for people with a small number of cancer spots that have spread. The goal is to find a treatment that is just as effective but more convenient and with fewer side effects.
Hear when a new Metastatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.